P19447 (ERCC3_HUMAN) Homo sapiens (Human)

General transcription and DNA repair factor IIH helicase/translocase subunit XPB UniProtKBInterProSTRINGInteractive Modelling

782 aa; Sequence (Fasta)

Available Structures

39 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of the human apo TFIIH Heteromer
P18074; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759;
30-728
100.0SF4;ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
30-728
100.0MG; 17×ZN;SF4;
Cryo-EM structure of the human TFIIH core complex Heteromer
P18074; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759;
34-730
90.91SF4;ZN;
RNA polymerase II pre-initiation complex with the proximal +1 nucleosome (PIC-Nuc10W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
34-730
100.0SF4; 16×ZN;MG;
Initial DNA-lesion (AP) binding by XPC and TFIIH complex2 Heteromer
P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-723
100.0SF4;ZN;CA;
Initial DNA-lesion (AP) binding by XPC and TFIIH complex 1 Heteromer
P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-723
100.0SF4;ZN;CA;
XPC release from Core7-XPA-DNA (Cy5) Heteromer
P18074; P23025; P32780; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-722
100.0SF4;ZN;
XPC release from Core7-XPA-DNA (AP) Heteromer
P18074; P23025; P32780; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-722
100.0SF4;ZN;
XPA repositioning Core7 of TFIIH relative to XPC-DNA lesion (AP) Heteromer
P18074; P23025; P32780; P41208; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-722
100.0SF4;ZN;CA;
Structure of transcribing complex 9 (TC9), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
Structure of transcribing complex 5 (TC5), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
Structure of transcribing complex 8 (TC8), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
Structure of transcribing complex 6 (TC6), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
Structure of transcribing complex 3 (TC3), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;W0F;MG;
Structure of transcribing complex 4 (TC4), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
XPA repositioning Core7 of TFIIH relative to XPC-DNA lesion (Cy5) Heteromer
P18074; P23025; P32780; P41208; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-721
100SF4;ZN;CA;
Structure of transcribing complex 2 (TC2), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;W0F;MG;
Structure of transcribing complex 7 (TC7), the initially transcribing complex with Pol II positione… Heteromer
A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;W0F;
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
51-720
100.017×ZN;SF4;MG;
RNA polymerase II pre-initiation complex with the distal +1 nucleosome (PIC-Nuc18W) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4; 17×ZN;MG;
TFIIH in a pre-translocated state (without ADP-BeF3) Heteromer
P18074; P29083; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4;ZN;
TFIIH in a post-translocated state (with ADP-BeF3) Heteromer
P18074; P29083; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4;ZN;ADP;MG;BEF;
RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4; 17×ZN;MG;
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; A0JLT2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O43513; O60244; O75586; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
51-720
100.0SF4; 18×ZN;MG;
XPB-containing part of TFIIH in a post-translocated state (with ADP-BeF3) Heteromer
P29083; Q6ZYL4; Q92759;
51-720
100.0ADP;MG;BEF;
RNA polymerase II pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4; 15×ZN;ADP;MG;BEF;
RNA polymerase II pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
51-720
100.0SF4; 17×ZN;MG;
Initial DNA-lesion (Cy5) binding by XPC and TFIIH Heteromer
P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759;
52-720
100.0SF4;ZN;CA;
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
57-721
100.016×ZN;SF4;MG;
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
64-718
100.0MG; 16×ZN;SF4;
Structure of the core TFIIH-XPA-DNA complex Heteromer
P18074; P23025; Q13888; Q13889; Q6ZYL4; Q92759;
71-720
100.0SF4;ZN;
Core TFIIH-XPA-DNA complex with modelled p62 subunit Heteromer
P18074; P23025; P32780; Q13888; Q13889; Q6ZYL4; Q92759;
71-720
100.0SF4;ZN;
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
244-718
100MG; 11×ZN;
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
244-718
100MG; 10×ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
244-718
100MG; 11×ZN;
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
244-718
100MG; 11×ZN;
Human core TFIIH bound to DNA within the PIC Heteromer
P18074; Q13888; Q13889; Q6ZYL4; Q92759;
244-718
100
The cryo-EM structure of human TFIIH Heteromer
P18074; Q13888; Q13889; Q6ZYL4; Q92759;
265-728
99.78SF4;
Crystal structure of the C-terminal domain of human XPB/ERCC-3 excision repair protein at 1.80 Amonomer502-730
100

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8ebu.1.Amonomer0.6952-722
100.00
6o9m.1.Hmonomer0.5530-728
100.00